Freda C Lewis-hall - Net Worth and Insider Trading

Freda C Lewis-hall Net Worth

The estimated net worth of Freda C Lewis-hall is at least $288 Million dollars as of 2024-11-13. Freda C Lewis-hall is the Director, 10% Owner of SpringWorks Therapeutics Inc and owns about 8,611,092 shares of SpringWorks Therapeutics Inc (SWTX) stock worth over $285 Million. Freda C Lewis-hall is also the Executive Vice President of Pfizer Inc and owns about 121,592 shares of Pfizer Inc (PFE) stock worth over $3 Million. Details can be seen in Freda C Lewis-hall's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Freda C Lewis-hall has not made any transactions after 2019-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Freda C Lewis-hall

To

Freda C Lewis-hall Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Freda C Lewis-hall owns 8 companies in total, including Exact Sciences Corp (EXAS) , SpringWorks Therapeutics Inc (SWTX) , and 1Life Healthcare Inc (ONEM) among others .

Click here to see the complete history of Freda C Lewis-hall’s form 4 insider trades.

Insider Ownership Summary of Freda C Lewis-hall

Ticker Comapny Transaction Date Type of Owner
EXAS Exact Sciences Corp 2020-04-22 director
SWTX SpringWorks Therapeutics Inc 2020-05-20 director & 10 percent owner
ONEM 1Life Healthcare Inc 2020-01-30 director
LIMIT LIMIT 2013-09-16 Senior Vice President
LIMIT LIMIT 2014-12-04 director
LIMIT LIMIT 2008-06-18 EVP & Medicines Development
LIMIT LIMIT 2021-10-07 director
LIMIT LIMIT 2023-09-22 director

Freda C Lewis-hall Latest Holdings Summary

Freda C Lewis-hall currently owns a total of 2 stocks. Among these stocks, Freda C Lewis-hall owns 8,611,092 shares of SpringWorks Therapeutics Inc (SWTX) as of September 17, 2019, with a value of $285 Million and a weighting of 98.89%. Freda C Lewis-hall also owns 121,592 shares of Pfizer Inc (PFE) as of September 16, 2013, with a value of $3 Million and a weighting of 1.11%.

Latest Holdings of Freda C Lewis-hall

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SWTX SpringWorks Therapeutics Inc 2019-09-17 8,611,092 33.08 284,854,923
PFE Pfizer Inc 2013-09-16 121,592 26.19 3,184,494

Holding Weightings of Freda C Lewis-hall


Freda C Lewis-hall Form 4 Trading Tracker

According to the SEC Form 4 filings, Freda C Lewis-hall has made a total of 0 transactions in SpringWorks Therapeutics Inc (SWTX) over the past 5 years. The most-recent trade in SpringWorks Therapeutics Inc is the acquisition of 50,000 shares on September 17, 2019, which cost Freda C Lewis-hall around $900,000.

According to the SEC Form 4 filings, Freda C Lewis-hall has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 38,461 shares on September 16, 2013, which brought Freda C Lewis-hall around $1 Million.

Insider Trading History of Freda C Lewis-hall

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Freda C Lewis-hall Trading Performance

GuruFocus tracks the stock performance after each of Freda C Lewis-hall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Freda C Lewis-hall is 28.57%. GuruFocus also compares Freda C Lewis-hall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Freda C Lewis-hall within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Freda C Lewis-hall's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Freda C Lewis-hall

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -16.38 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -16.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Freda C Lewis-hall Ownership Network

Ownership Network List of Freda C Lewis-hall

No Data

Ownership Network Relation of Freda C Lewis-hall

Insider Network Chart

Freda C Lewis-hall Owned Company Details

What does Exact Sciences Corp do?

Who are the key executives at Exact Sciences Corp?

Freda C Lewis-hall is the director of Exact Sciences Corp. Other key executives at Exact Sciences Corp include Gen. Mgr. & Precision Oncology Brian Baranick , General Counsel James Herriott , and director & Vice President Kevin T Conroy .

Exact Sciences Corp (EXAS) Insider Trades Summary

Over the past 18 months, Freda C Lewis-hall made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 20,284 shares made by Sarah Condella , a net sale of 11,459 shares made by Brian Baranick , and a net sale of 5,403 shares made by James Herriott .

In summary, during the past 3 months, insiders sold 1,858 shares of Exact Sciences Corp (EXAS) in total and bought 0 shares, with a net sale of 1,858 shares. During the past 18 months, 170,352 shares of Exact Sciences Corp (EXAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 170,352 shares.

Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Exact Sciences Corp Insider Transactions

No Available Data

Freda C Lewis-hall Mailing Address

Above is the net worth, insider trading, and ownership report for Freda C Lewis-hall. You might contact Freda C Lewis-hall via mailing address: C/o Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge Ma 02139.